Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. AMA Code Says Dec 2002 CEJA to Present Three Reports with Recommendations to House of Delegates Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):361-362. doi: 10.1001/virtualmentor.2002.4.12.code1-0212. Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022;24(3):E181-187. doi: 10.1001/amajethics.2022.181. Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022;24(3):E212-217. doi: 10.1001/amajethics.2022.212. Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226. Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
AMA Code Says Dec 2002 CEJA to Present Three Reports with Recommendations to House of Delegates Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):361-362. doi: 10.1001/virtualmentor.2002.4.12.code1-0212.
Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022;24(3):E181-187. doi: 10.1001/amajethics.2022.181.
Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022;24(3):E212-217. doi: 10.1001/amajethics.2022.212.
Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226.
Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.